Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 9 of 9  Show

Literature citations Results

The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.

Greggio E., Taymans J.M., Zhen E.Y., Ryder J., Vancraenenbroeck R., Beilina A., Sun P., Deng J., Jaffe H., Baekelandt V. et al.

Biochem. Biophys. Res. Commun. 389:449-454(2009) · Mapped (5)

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

Cho H.J., Liu G., Jin S.M., Parisiadou L., Xie C., Yu J., Sun L., Ma B., Ding J., Vancraenenbroeck R. et al.

Hum. Mol. Genet. 22:608-620(2013) · Mapped (8)

LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.

Taymans J.M., Vancraenenbroeck R., Ollikainen P., Beilina A., Lobbestael E., De Maeyer M., Baekelandt V., Cookson M.R.

PLoS ONE 6:e23207-e23207(2011) · Mapped (5)

Interplay between HIV entry and transportin-SR2 dependency.

Thys W., De Houwer S., Demeulemeester J., Taltynov O., Vancraenenbroeck R., Gerard M., De Rijck J., Gijsbers R., Christ F., Debyser Z.

Retrovirology 8:7-7(2011) · Mapped (5)

Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Daniels V., Vancraenenbroeck R., Law B.M., Greggio E., Lobbestael E., Gao F., De Maeyer M., Cookson M.R., Harvey K., Baekelandt V. et al.

J. Neurochem. 116:304-315(2011) · Mapped (5)

In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2.

Vancraenenbroeck R., De Raeymaecker J., Lobbestael E., Gao F., De Maeyer M., Voet A., Baekelandt V., Taymans J.M.

Front Mol Neurosci 7:51-51(2014) · Mapped (1)

Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.

Vancraenenbroeck R., Lobbestael E., Weeks S.D., Strelkov S.V., Baekelandt V., Taymans J.M., De Maeyer M.

Biochim. Biophys. Acta 1824:450-460(2012) · Mapped (5)

Conformational (in)stability of rat vs. human activated thrombin activatable fibrinolysis inhibitor.

Hillmayer K., Ceresa E., Vancraenenbroeck R., Declerck P.J., Gils A.

J. Thromb. Haemost. 6:1426-1428(2008) · Mapped (1)

Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.

Civiero L., Vancraenenbroeck R., Belluzzi E., Beilina A., Lobbestael E., Reyniers L., Gao F., Micetic I., De Maeyer M., Bubacco L. et al.

PLoS ONE 7:E43472-E43472(2012) · UniProtKB (2) · Mapped (12)

1 to 9 of 9  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again